Literature DB >> 4214572

An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations.

P T Otis, D I Feinstein, S I Rapaport, M J Patch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4214572

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Case report of an acquired factor XIII inhibitor: diagnosis and management.

Authors:  Thomas F Gregory; Barry Cooper
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-07

Review 2.  Acquired FXIII inhibitors: a systematic review.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

Review 3.  [Blood coagulation factor XIII and fibrin stabilization (author's transl)].

Authors:  H Rasche
Journal:  Klin Wochenschr       Date:  1975-12-15

4.  Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII.

Authors:  G R Milner; P J Holt; J Bottomley; J E Maciver
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

5.  Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis.

Authors:  Masatake Matsuoka; Tokifumi Majima; Tomohiro Onodera; Masahiro Ieko; Masayoshi Souri; Akitada Ichinose; Takashi Kurita; Yasuhiko Kasahara; Masahiro Inoue; Daisuke Takahashi
Journal:  Int J Hematol       Date:  2012-10-16       Impact factor: 2.490

6.  Nonhemophiliac musculoskeletal pseudotumor.

Authors:  Indrani Sen; Dheepak Selvaraj; Prabhu Premkumar; Sunil Agarwal
Journal:  J Vasc Surg Cases       Date:  2015-06-19

7.  Drug-induced hematologic syndromes.

Authors:  David M Mintzer; Shira N Billet; Lauren Chmielewski
Journal:  Adv Hematol       Date:  2009-07-07

Review 8.  Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literature.

Authors:  Maria A P Martins; Adriano M M Reis; Mariana F Sales; Vandack Nobre; Daniel D Ribeiro; Manoel O C Rocha; Antônio L P Ribeiro
Journal:  BMC Pharmacol Toxicol       Date:  2013-05-04       Impact factor: 2.483
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.